USTR 301 report spells out big pharma’s Asian patent concerns
The office of the United States Trade Representative has just released its annual 301 Special Report, a review of the state of intellectual property rights and their enforcement around the world. Although comprehensive in scope, the report makes…
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.